Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Identifieur interne : 000449 ( Main/Exploration ); précédent : 000448; suivant : 000450

The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Auteurs : Kenneth Maiese [États-Unis]

Source :

RBID : pubmed:29523769

Descripteurs français

English descriptors

Abstract

As a result of the advancing age of the global population and the progressive increase in lifespan, neurodegenerative disorders continue to increase in incidence throughout the world. New strategies for neurodegenerative disorders involve the novel pathways of the mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1) that can modulate pathways of apoptosis and autophagy. The pathways of mTOR and SIRT1 are closely integrated. mTOR forms the complexes mTOR Complex 1 and mTOR Complex 2 and can impact multiple neurodegenerative disorders that include Alzheimer's disease, Huntington's disease, and Parkinson's disease. SIRT1 can control stem cell proliferation, block neuronal injury through limiting programmed cell death, drive vascular cell survival, and control clinical disorders that include dementia and retinopathy. It is important to recognize that oversight of programmed cell death by mTOR and SIRT1 requires a fine degree of precision to prevent the progression of neurodegenerative disorders. Additional investigations and insights into these pathways should offer effective and safe treatments for neurodegenerative disorders.

DOI: 10.1042/BST20170121
PubMed: 29523769
PubMed Central: PMC5906169


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.</title>
<author>
<name sortKey="Maiese, Kenneth" sort="Maiese, Kenneth" uniqKey="Maiese K" first="Kenneth" last="Maiese">Kenneth Maiese</name>
<affiliation wicri:level="2">
<nlm:affiliation>Cellular and Molecular Signaling, Newark, NJ 07101, U.S.A. wntin75@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cellular and Molecular Signaling, Newark, NJ 07101</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29523769</idno>
<idno type="pmid">29523769</idno>
<idno type="doi">10.1042/BST20170121</idno>
<idno type="pmc">PMC5906169</idno>
<idno type="wicri:Area/Main/Corpus">000599</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000599</idno>
<idno type="wicri:Area/Main/Curation">000599</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000599</idno>
<idno type="wicri:Area/Main/Exploration">000599</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.</title>
<author>
<name sortKey="Maiese, Kenneth" sort="Maiese, Kenneth" uniqKey="Maiese K" first="Kenneth" last="Maiese">Kenneth Maiese</name>
<affiliation wicri:level="2">
<nlm:affiliation>Cellular and Molecular Signaling, Newark, NJ 07101, U.S.A. wntin75@yahoo.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cellular and Molecular Signaling, Newark, NJ 07101</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Biochemical Society transactions</title>
<idno type="eISSN">1470-8752</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Apoptosis (MeSH)</term>
<term>Cell Survival (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Neurodegenerative Diseases (metabolism)</term>
<term>Saccharomyces cerevisiae (metabolism)</term>
<term>Sirtuin 1 (metabolism)</term>
<term>TOR Serine-Threonine Kinases (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Apoptose (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Maladies neurodégénératives (métabolisme)</term>
<term>Saccharomyces cerevisiae (métabolisme)</term>
<term>Sirtuine-1 (métabolisme)</term>
<term>Survie cellulaire (MeSH)</term>
<term>Sérine-thréonine kinases TOR (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Sirtuin 1</term>
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Neurodegenerative Diseases</term>
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Maladies neurodégénératives</term>
<term>Saccharomyces cerevisiae</term>
<term>Sirtuine-1</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Apoptosis</term>
<term>Cell Survival</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Apoptose</term>
<term>Humains</term>
<term>Survie cellulaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">As a result of the advancing age of the global population and the progressive increase in lifespan, neurodegenerative disorders continue to increase in incidence throughout the world. New strategies for neurodegenerative disorders involve the novel pathways of the mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (
<i>Saccharomyces cerevisiae</i>
) (SIRT1) that can modulate pathways of apoptosis and autophagy. The pathways of mTOR and SIRT1 are closely integrated. mTOR forms the complexes mTOR Complex 1 and mTOR Complex 2 and can impact multiple neurodegenerative disorders that include Alzheimer's disease, Huntington's disease, and Parkinson's disease. SIRT1 can control stem cell proliferation, block neuronal injury through limiting programmed cell death, drive vascular cell survival, and control clinical disorders that include dementia and retinopathy. It is important to recognize that oversight of programmed cell death by mTOR and SIRT1 requires a fine degree of precision to prevent the progression of neurodegenerative disorders. Additional investigations and insights into these pathways should offer effective and safe treatments for neurodegenerative disorders.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29523769</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>09</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>04</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1470-8752</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>46</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2018</Year>
<Month>04</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>Biochemical Society transactions</Title>
<ISOAbbreviation>Biochem Soc Trans</ISOAbbreviation>
</Journal>
<ArticleTitle>The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.</ArticleTitle>
<Pagination>
<MedlinePgn>351-360</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1042/BST20170121</ELocationID>
<Abstract>
<AbstractText>As a result of the advancing age of the global population and the progressive increase in lifespan, neurodegenerative disorders continue to increase in incidence throughout the world. New strategies for neurodegenerative disorders involve the novel pathways of the mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (
<i>Saccharomyces cerevisiae</i>
) (SIRT1) that can modulate pathways of apoptosis and autophagy. The pathways of mTOR and SIRT1 are closely integrated. mTOR forms the complexes mTOR Complex 1 and mTOR Complex 2 and can impact multiple neurodegenerative disorders that include Alzheimer's disease, Huntington's disease, and Parkinson's disease. SIRT1 can control stem cell proliferation, block neuronal injury through limiting programmed cell death, drive vascular cell survival, and control clinical disorders that include dementia and retinopathy. It is important to recognize that oversight of programmed cell death by mTOR and SIRT1 requires a fine degree of precision to prevent the progression of neurodegenerative disorders. Additional investigations and insights into these pathways should offer effective and safe treatments for neurodegenerative disorders.</AbstractText>
<CopyrightInformation>© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Maiese</LastName>
<ForeName>Kenneth</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Cellular and Molecular Signaling, Newark, NJ 07101, U.S.A. wntin75@yahoo.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 NS053946</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>03</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Biochem Soc Trans</MedlineTA>
<NlmUniqueID>7506897</NlmUniqueID>
<ISSNLinking>0300-5127</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.1.-</RegistryNumber>
<NameOfSubstance UI="D056564">Sirtuin 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D056564" MajorTopicYN="N">Sirtuin 1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">cell death</Keyword>
<Keyword MajorTopicYN="Y">molecular disease</Keyword>
<Keyword MajorTopicYN="Y">signaling</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>11</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>02</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>02</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>3</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29523769</ArticleId>
<ArticleId IdType="pii">BST20170121</ArticleId>
<ArticleId IdType="doi">10.1042/BST20170121</ArticleId>
<ArticleId IdType="pmc">PMC5906169</ArticleId>
<ArticleId IdType="mid">NIHMS954527</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Pharmacol Res. 2017 May;119:1-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28126510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Gerontol. 2014 Feb;50:137-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24211426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CNS Drugs. 2017 Jul;31(7):535-549</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28540646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Restor Neurol Neurosci. 2014;32(5):689-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25015703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Muscle Res Cell Motil. 2017 Apr;38(2):201-214</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28634643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cardiovasc Dis. 2017 Apr 15;7(2):33-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28533928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathobiology. 2016;83(4):211-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27116685</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathol Res Pract. 2016 Apr;212(4):310-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26872534</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oxid Med Cell Longev. 2015;2015:875961</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26064426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Sci. 2016 Mar;2(2):140-144</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27081573</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Res. 2012 Jun;73(2):99-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22465415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neural Regen Res. 2016 Mar;11(3):372-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27127460</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Med. 2014 Jul;34(1):177-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24718722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurochem. 2010 Jan;112(2):366-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19878437</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2017 Aug 3;13(8):1348-1363</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28598226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Apoptosis. 2016 May;21(5):621-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26897171</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2017 Mar 1;37(9):2449-2462</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28137967</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Gerontol. 2010 Mar;45(3):217-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20064603</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Neurobiol. 2018 Jan;38(1):73-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28699112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2015 Jul 14;5:12115</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26169250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neural Regen Res. 2015 Apr;10(4):518-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26170801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 May 04;6:25226</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27142962</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Environ Toxicol. 2017 Jan;32(1):109-121</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26588882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2010 May;7(2):95-112</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20370652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Molecules. 2017 May 27;22(6):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28555021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Med. 2014 Dec;46(8):587-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25105207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med Rep. 2015 Aug;12(2):2771-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25976650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Transplant. 2014;23(4-5):549-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24816450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroinflammation. 2014 Aug 27;11:139</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25158693</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2012 Oct 26;13(11):13830-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23203037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Interdiscip Top Gerontol. 2015;40:107-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25341517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2015 Oct 27;6(33):34446-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26439987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Jun 18;10(6):e0128651</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26087293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Mol Med. 2013 Jan;19(1):51-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23265840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Res Int. 2014;2014:783459</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25243179</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2011 Aug 1;8(3):220-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21722091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Alzheimers Dis. 2017;59(2):615-631</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28671110</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2017;14 (3):299-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28721811</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rejuvenation Res. 2016 Mar 16;:null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26725653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nutr Biochem. 2016 Oct;36:31-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27567590</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chim Acta. 2014 Nov 1;437:106-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25063737</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2008 Aug;5(3):159-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18691073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurol. 2016 Jul;12(7):379-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27340022</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Proteome Res. 2014 May 2;13(5):2433-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24694195</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2017;14 (3):199</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28738775</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroinflammation. 2013 Dec 13;10:151</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24330807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Cell. 2014 Dec;13(6):1075-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25257342</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurochem Res. 2015 Apr;40(4):698-712</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25585642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Apoptosis. 2017 Feb;22(2):265-283</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27807740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ageing Res Rev. 2016 Nov;31:9-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27524412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurobiol. 2016 Aug;53(6):3812-3821</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26156288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Aug 24;6:32206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27553905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2016;13(4):329-340</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27488211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2015;12(2):173-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25742566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Endocrinol. 2016 Apr;30(4):446-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26900721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2016 Oct 13;7(10 ):e2416</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27735947</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Matern Fetal Neonatal Med. 2012 Apr;25 Suppl 1:30-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22385271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci China Life Sci. 2017 Nov;60(11):1234-1241</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28667519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Alzheimers Dis. 2015 ;44(4):1145-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25408212</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 2013 Aug 14;1526:94-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23806777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cogn Behav Neurol. 2007 Sep;20(3):149-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17846513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Lett. 2017 Jun 5;275:28-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28456571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prog Neurobiol. 2012 Nov;99(2):128-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22980037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vet Sci. 2017 Mar 30;18(1):11-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27297423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Stem Cells. 2015 Aug 26;7(7):999-1009</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26328016</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biochem Pharmacol Res. 2013 Jun;1(2):84-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23826514</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2012 Jan 2;287(1):581-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22084251</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Nutr Food Res. 2014 Oct;58(10):1941-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25047736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2017 Apr 5;37(14 ):3824-3839</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28275163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Nutr Food Res. 2015 Oct;59(10 ):1905-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26202455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Pharmacol. 2014 Jan;171(2):523-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24372553</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Sci. 2016;2(3):185-187</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27200181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicology. 2016 Feb 3;341-343:28-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26804764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 May 31;18(6):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28561773</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2017 Jan 23;7:41082</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28112228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Pharm Bull. 2014;37(7):1248-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24989016</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med Rep. 2016 Apr;13(4):3539-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26936536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychiatr Dis Treat. 2017 Mar 20;13:835-842</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28360521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Med Genet. 2014 Oct 02;15:112</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25273948</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lab Invest. 2010 May;90(5):762-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20142804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2015 Jan 06;5:7645</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25561289</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2011 May 1;71(9):3246-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21430067</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2008 Oct 10;283(41):27810-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18678867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2017;14 (1):82-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27897112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Lett. 2013 Aug;6(2):600-604</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24137378</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Jul 16;10(7):e0132768</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26182057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2013 Feb;10(1):29-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23244622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21157483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stem Cells. 2013 Dec;31(12):2813-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23897750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Oct 14;10 (10 ):e0139664</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26466127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Sci. 2015 Nov;1(3):55-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26561536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastrointestin Liver Dis. 2014 Sep;23(3):311-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25267960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2016;12 (1):1-222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26799652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Aug 12;10(8):e0135614</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26267903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2017 Sep;74(18):3347-3362</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28417163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 2014 Jan 13;1542:12-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24505621</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2013 Aug 7;33(32):13138-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23926267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Sci. 2016 Jul;2(4):241-247</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27390624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2015;12(4):404-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26256004</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Ther Targets. 2012 Feb;16(2):167-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22233091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prog Neurobiol. 2005 Feb;75(3):207-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15882775</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuron. 2015 Jan 21;85(2):303-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25556834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Diabetes. 2015 Mar 15;6(2):217-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25789103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 2016 Oct 15;299:164-171</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27725116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CNS Neurosci Ther. 2015 Jan;21(1):8-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25146548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nat Med. 2012 Jul;66(3):544-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22318341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurotrauma. 2012 Mar 20;29(5):946-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21806471</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neural Regen Res. 2014 Aug 1;9(15):1413-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25317149</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Physiol. 2018 Jun;233(6):4783-4790</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29165795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(1):e30012</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22253859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Neurosci. 2017 Apr;61(4):581-589</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28238066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Future Cardiol. 2012 Jan;8(1):89-100</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22185448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2017;14 (4):415-420</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29149835</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Neurosci. 2011 Jun;47(2):145-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21463685</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2017 Dec;1868(2):341-358</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28694093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2012 Nov;9(4):239-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22873724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Neurosci. 2013 Jan;49(1):105-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23065334</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Prog Mol Biol Transl Sci. 2011;99:265-305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21238939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2011 Jan 28;404(4):941-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21185267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging (Albany NY). 2012 Mar;4(3):187-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22388478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Neurodegener. 2017 Jan 25;12 (1):11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28122627</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Drug Discov. 2013 Jan;8(1):35-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23092114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2016 Oct 28;291(44):23318-23329</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27634039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Pharmacol. 2017 May 29;8:315</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28611667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 2016 Nov;82(5):1245-1266</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26469771</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Molecules. 2015 Jan 23;20(2):1904-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25625683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurol Res. 2017 Oct;39(10 ):904-909</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28782464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2018 Apr;67(4):745-754</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29311218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Peptides. 2016 Dec;86:102-111</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27777064</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Endocrinol. 2018 Apr;178(4):R113-R125</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29371333</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Res. 2015 Mar;61(3):187-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25281273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CNS Neurol Disord Drug Targets. 2017;16(6):724-736</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28124619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Lett. 2011 Jan 20;488(2):112-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20849920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res. 2018 Jan 1;1678 :106-115</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29056525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IET Syst Biol. 2014 Aug;8(4):169-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25075530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Aging Neurosci. 2013 Jul 23;5:36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23888142</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cardiovasc Diabetol. 2012 Jul 16;11:45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22545721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oxid Med Cell Longev. 2010 Nov-Dec;3(6):374-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21307646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Ther Targets. 2012 Dec;16(12):1203-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22924465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2014 May 23;448(1):89-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24755072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Apr 05;11(4):e0152931</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27045591</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Des Devel Ther. 2014 Oct 08;8:1765-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25336920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Pharmacol. 2012 Jan 1;83(1):16-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21964343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ScientificWorldJournal. 2014;2014:937051</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25184156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Clin Exp Res. 2016 Apr;28(2):303-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26138818</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med Rep. 2018 Jan;17 (1):131-137</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29115479</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 2012 Jan 1;318(1):33-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21925170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Mol Med. 2017 Dec;21(12 ):3204-3213</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28643459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stem Cells Int. 2017;2017:4782820</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28883836</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obesity (Silver Spring). 2016 Feb;24(2):417-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26694743</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Chin Med. 2013;41(6):1329-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24228604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Alzheimers Dement. 2017 Jun;13(6):689-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27883893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheumatol. 2014 Dec;66(12 ):3349-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25186470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutr Metab Cardiovasc Dis. 2016 Jun;26(6):489-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27033026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rom J Morphol Embryol. 2011;52(4):1173-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22203920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Eye Res. 2010 Nov;91(5):601-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20696157</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neuropharmacol. 2016;14 (8):810-825</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26997506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Res Bull. 2015 Jul;116:67-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26135885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Stem Cells. 2015 Mar 26;7(2):235-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25815111</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Surg Res. 2015 Mar;194(1):127-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25472572</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stem Cells. 2014 May;32(5):1183-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24449278</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Res. 2012 May;10(5):649-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22426462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 2016 Mar;161(3):621-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26660162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2014 May;11(2):177-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24712647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Cell Pathol (Amst). 2015;2015:569392</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26171319</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Res Rev. 2014 May;34(3):644-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24002940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2017;14 (2):184-189</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28294062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2012 Oct 10;13(10 ):12939-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23202931</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 2017;982:407-429</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28551800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biofactors. 2017 Jul 8;43(4):540-548</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28317262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2017 Feb 17;292(7):2571-2585</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28011637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurovasc Res. 2009 Nov;6(4):223-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19807657</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Signal. 2010 Sep;22(9):1317-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20462515</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>New Jersey</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="New Jersey">
<name sortKey="Maiese, Kenneth" sort="Maiese, Kenneth" uniqKey="Maiese K" first="Kenneth" last="Maiese">Kenneth Maiese</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000449 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000449 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29523769
   |texte=   The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29523769" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020